Atlatl Advisers LLC Purchases New Stake in Illumina, Inc. $ILMNDefense World · 1 day ago
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research · 3 days ago
Illumina: NovaSeq X And Consumables Sustain MomentumSeeking Alpha · 3 days ago
ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift PerformanceZacks Investment Research · 3 days ago
Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discoveryPRNewsWire · 4 days ago
Illumina To Webcast Upcoming Investor ConferencePRNewsWire · 5 days agoIllumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 30, 2026 | $1.23 | $1.31 | Beat |
| Apr 30, 2026 | $1.05 | $1.15 | Beat |
| Feb 5, 2026 | $1.24 | $1.35 | Beat |
| Oct 30, 2025 | $1.17 | $1.34 | Beat |
| Jul 31, 2025 | $1.02 | $1.19 | Beat |
| May 8, 2025 | $0.94 | $0.97 | Beat |